The Legend Holdings-backed digital medical platform has raised fresh capital for a series A round led by Qiming Venture Partners.
Liangyihui, a China-based digital medical platform focused on oncology and backed by conglomerate Legend Holdings, has collected more than RMB100m ($15.5m) in a series C round led by Qiming Venture Partners, DealStreetAsia reported yesterday. The round also featured new investors DT Capital Partners, Yuanju Capital Management and Wang Jiaquan’s family office as well as existing…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.